Back to News
Market Impact: 0.3
What Repligen (RGEN) Said on Its Q3 Earnings Call
Source: marketbeat.com
Corporate EarningsCompany FundamentalsHealthcare & Biotech
Repligen reported record third-quarter 2026 revenue of $209 million, exceeding its prior quarterly peak from Q2 2022. Growth in Proteins, Chromatography and Analytics offset weakness in Filtration.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.30
Ticker Sentiment
RGEN0.75
More News
- SK Hynix Posts Record Profit Amid AI Rush
- SK Hynix third-quarter profit sharply beats estimates on AI memory boost
- Anthropic's IPO could be 'speculative fiction' or a 'generational moment' — investors are split
- Tech's relief rally extends as attention turns to tough decisions for the Fed
- Anthropic Gives Traders a Pure-Play Bet on Frontier AI
- Analysis-Hold or sell? High Treasury yields spur US banks to rethink bond portfolios